Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/500420 stock hub

BOM/500420 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/500420is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.5T
Bombay Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BOM/500420
In the news

Latest news · BOM/500420

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E80.9
P25 n/aP50 n/aP75 n/a
Trailing P/E65.3
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC24.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/500420 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
194
Groups with data
10
Currency
INR
Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
17,059
Employees Change
1,341%
Employees Change Percent
8.53
Enterprise value
INR 1.5T
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
INR 1.5T
Price
INR 4,380
Price currency
INR
Rev Per Employee
7,469,423.76x
Sic
2834
Symbol
bom/500420
Website
https://www.torrentpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
1.53%
EV Earnings
66.14x
EV/EBIT
44.79x
EV/EBITDA
36.41x
EV/Sales
11.79x
Forward P/E
80.86x
P/B ratio
17.55x
P/E ratio
65.26x
P/S ratio
11.63x
PE Ratio10 Y
44.72x
PE Ratio3 Y
54.58x
PE Ratio5 Y
53.27x
PEG ratio
4.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
26.33%
EBITDA Margin
32.2%
Gross margin
75.64%
Gross Profit
INR 96.4B
Gross Profit Growth
12.36%
Gross Profit Growth Q
17.23%
Gross Profit Growth3 Y
13.42%
Gross Profit Growth5 Y
10.56%
Net Income
INR 22.7B
Net Income Growth
22.01%
Net Income Growth Q
26.24%
Net Income Growth3 Y
39.83%
Net Income Growth5 Y
12.85%
Pretax Margin
23.61%
Profit Margin
17.83%
Profit Per Employee
INR 1.3M
Roa5y
9.73
Roe5y
21.8
ROIC
24.19
Roic5y
15.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
21.6%
Cagr15y
26.96%
Cagr1y
34.34%
Cagr20y
25.49%
Cagr3y
39.95%
Cagr5y
28.97%
Div CAGR10
10.31%
Div CAGR3
11.13%
Div CAGR5
28.47%
EPS Growth
21.97
EPS Growth Q
26.14
EPS Growth3 Y
39.85
EPS Growth5 Y
12.84
Revenue Growth
12.74x
Revenue Growth Q
17.59x
Revenue Growth3 Y
11.23x
Revenue Growth5 Y
9.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 7.9B
Debt
INR 28.2B
Debt EBITDA
INR 0.68
Debt Equity
INR 0.33
Equity
INR 84.5B
Interest Coverage
16.42
Net Cash
INR -20.3B
Net Cash By Market Cap
INR -1.37
Net Debt EBITDA
INR 0.49
Net Debt Equity
INR 0.24
Tangible Book Value
INR 40.7B
Tangible Book Value Per Share
INR 120
WACC
5.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.03%
Dividend Growth
9.38%
Dividend Growth Years
2%
Dividend per share
INR 32
Dividend Years
27
Dividend Yield
0.73%
Ex Div Date
2026-02-18
Last Dividend
INR 29
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
606.43%
1Y total return
34.31%
200-day SMA
3,863.2
3Y total return
174.19%
50-day SMA
4,246.9
50-day SMA vs 200-day SMA
50over200
5Y total return
256.69%
All Time High
4,479.7
All Time High Change
-2.22%
All Time High Date
2026-03-13
All Time Low
3.53
All Time Low Change
123,883.87%
All Time Low Date
2001-04-12
ATR
95.74
Beta
0.14
Beta1y
0.39
Beta2y
0.34
Ch YTD
14.02
High
4,399
High52
4,479.7
High52 Date
2026-03-13
High52ch
-2.22%
Low
4,339.6
Low52
3,101
Low52 Date
2025-05-09
Low52ch
41.26%
Ma50ch
3.14%
Price vs 200-day SMA
13.39%
RSI
64.1
RSI Monthly
73.84
RSI Weekly
67.06
Sharpe ratio
1.43x
Sortino ratio
2.71
Total Return
0.7%
Tr YTD
14.8
Tr15y
3,488.39%
Tr1m
8.18%
Tr1w
3.02%
Tr3m
11.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 33.6B
Operating Income Growth
17.5
Operating Income Growth Q
23.36
Operating Income Growth3 Y
18.85
Operating Income Growth5 Y
13.35
Operating margin
26.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
103,982,880%
Shares Insiders
0.28%
Shares Institutions
17.44%
Shares Out
338,445,440
Shares Qo Q
-0.11%
Shares Yo Y
0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Average Volume
14,247x
Bv Per Share
249.5
Ch10y
527.9
Ch15y
2,752.9
Ch1m
8.18
Ch1w
3.02
Ch1y
33.15
Ch20y
6,769.7
Ch3m
11.19
Ch3y
165.8
Ch5y
234.9
Ch6m
22.37
Change
0.49%
Change From Open
0.19
Close
4,359
Days Gap
0.3
Depreciation Amortization
7,476,675,000
Dollar Volume
16,005,798.9
Earnings Date
2026-05-22
EBIT
INR 33.6B
EBITDA
INR 41B
EPS
INR 67.12
F Score
1
Fiscal Year End
March
Founded
1,959
Graham Number
613.79374
Graham Upside
-85.99
Income Tax
INR 7.4B
Is Primary Listing
1
Last Earnings Date
2026-01-23
Last Report Date
2025-12-31
Last Split Date
2022-07-08
Last Split Type
Forward
Lynch Fair Value
INR 862
Lynch Upside
-80.32
Ma150
3,950.7
Ma150ch
10.87%
Ma20
4,201.7
Ma20ch
4.25%
Next Earnings Date
2026-05-22
Open
4,372.1
Payment Date
2026-03-15
Position In Range
68.6
Price Date
2026-05-08
Price EBITDA
INR 36.13
Ptbv Ratio
36.46
Relative Volume
0.26x
Revenue
127,420,900,000x
Tax By Revenue
5.77x
Tax Rate
24.46%
Tr20y
9,277.97%
Tr6m
23.21%
Volume
3,654
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BOM/500420 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.7%
$32.0 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+28.5%
2 consecutive years of growth
Total shareholder yield
+0.7%
Next ex-dividend date: 2026-02-18
Performance

BOM/500420 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+34.3%
S&P 500 1Y: n/a
3Y total return
+174.2%
S&P 500 3Y: n/a
5Y total return
+256.7%
S&P 500 5Y: n/a
10Y total return
+606.4%
S&P 500 10Y: n/a
Ownership

Who owns BOM/500420?

Insider, institutional, and short-interest positioning.

Institutional ownership
+17.4%
Share of float held by funds and institutions
Insider ownership
+0.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

BOM/500420 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.1
Neutral momentum band
Price vs 200-day MA
+13.4%
50/200-day relationship not available
Beta (5Y)
0.14
Less volatile than the market
Sharpe ratio
1.43
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/500420

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/500420 stock rating?

bom/500420 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/500420 analysis?

The full report lives at /stocks/bom/500420/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/500420?

The latest report frames bom/500420 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/500420 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bom/500420 stock profile: metrics, valuation and analysis | StockMarketAgent.AI